The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Glossary Glossary
The Body Covers: The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment
Keynote Speech

July 8, 2001

To view a video of this presentation, click here
Please note: Best viewed with Internet Explorer.
(Requires Real Player for Windows or Macintosh)

  • Fostering Access to HIV/AIDS Care and Treatment (Presentation PL3)
    Speaker: Stefano Vella
    Instituto Superiore Di Sanità, Rome, Italy

Stefano Vella was the final speaker. He is the President of the International AIDS Society and has been instrumental in the switch to the "South" that has happened in the last two years in the HIV research arena. I still remember his powerful speech at the magical Durban Conference. He said then that the International AIDS Conference should be held in the underdeveloped world and he has kept his promise. The next one has been moved from Toronto to Bangkok. Stefano Vella deserves a lot of credit for that.

He gave us the somber global picture of AIDS: how this epidemic is affecting the entire world and what the sobering predictions are for the coming decades.

AIDS, he reminded us, reverses decades of economic development in Africa and brings back life expectancies not seen in the last 2,000 years (there is no typo here: 2,000 years!). AIDS is a global catastrophe of unbelievable proportions. AIDS is currently the leading cause of death in Africa. During the last two years we have witnessed a dramatic change in the politics of AIDS. We are well aware of the global threat of this disease, and how it is affecting the political stability and economy in half of this world. The conference at Durban was useful in raising awareness of the AIDS issue around the scientific communities in the world and was an important factor in "Declaration of Commitment on HIV/AIDS" of the recent United Nations Special Session on HIV/AIDS.

The question for all of us as scientists is how to bring antiretroviral therapy to the developing world. We know that these therapies are "cost effective" in the developed world, and we have a moral obligation to develop sustainable means of extending the benefits to the whole world.

Dr. Vella attempted to discount the arguments against the quick implementation of therapy in the developing world. He pointed out that the cost of therapy is coming down, that through compulsory licensing many countries are getting access to generic drugs and that the drug companies have an interest in reducing the prices of these medicines. Also that rich countries have to commit the funds to pay for these expensive drugs and that the governments of developing countries have to pledge to develop the necessary health infrastructures. Therapies have to be made simpler, so they can be given to large populations. We, the rich, have an important responsibility in the training of health care providers to provide excellent care in the management of HIV. Easy access to these drugs will certainly increase the rate of resistance, and surveillance programs will be necessary to monitor this problem, but that is not a good argument not to treat now. The need for further clinical and basic research should not be used as an argument to delay the initiation of these programs. Therapy and research should go together, as they did in the "first world" during the last decade.

He ended with a beautiful African proverb: "The best time to plant a tree is 40 years ago, the second best time is now."

Previous | Next (Day Two)

Click here to take our survey and let us know what you think of our coverage!

See Also
More HIV Policy and Funding News on HIV in the Developing World

  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by The Body PRO. Copyright © Body Health Resources Corporation. All rights reserved.

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.